On June 8, 2022 Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, reported three presentations at upcoming investor and industry conferences. Jak Knowles, M.D., Co-founder, President and Chief Executive Officer of Affini-T Therapeutics, will present at each discussing the company’s T cell receptor (TCR) discovery platform, lead programs targeting KRAS G12V and G12D and clinical-stage program against Merkel cell carcinoma (Press release, Affini-T Therapeutics, JUN 8, 2022, View Source [SID1234615782]). A copy of the company’s corporate presentation and webcast link will be available under Corporate Presentations in the News section of its website following the meetings.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"This is an exciting time for KRAS and T cell receptor therapies given the significant advances in research, including the recent report in The New England Journal of Medicine that details the promising clinical response of a patient with metastatic pancreatic cancer by targeting the KRAS G12D driver mutation," said Dr. Knowles. "At these upcoming meetings, we look forward to connecting with investor and industry contacts to discuss how we can work together to unlock the full potential of this field and bring potentially curative treatments to patients facing some of the most difficult-to-treat solid tumor cancers."
Presentation details are as follows:
Conference: Jefferies Global Healthcare Conference (access to webcast)
Date: June 8, 2022
Time: 4:30 pm EDT
Location: New York, New York
Conference: BIO International Convention
Date: June 13, 2022
Time: 03:30 pm PDT
Location: San Diego, California
Conference: JMP Securities Life Sciences Conference
Date: June 15, 2022
Time: 12:00 pm EDT
Location: New York, New York